ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer
Authors
Alice Shaw,
Benjamin SolomonBenjamin Besse,
Todd Bauer,
Chia‐Chi Lin,
Ross Soo,
Gregory Riely,
Sai‐Hong Ou,
Jill Clancy,
Sherry Li,
Antonello Abbattista,
Holger Thurm,
Miyako Satouchi,
D. Camidge,
Steven Kao,
Rita Chiari,
Shirish Gadgeel,
Enriqueta Felip +16 authors
,
Jean‐François Martini Tip Tip